148720-14-3 Usage
Type of Medication
Synthetic anti-thyroid medication
Purpose
Treats hyperthyroidism (overactive thyroid)
Mechanism of Action
Inhibits the production of thyroid hormones
Symptoms Reduced
Weight loss, rapid heartbeat, tremors
Route of Administration
Orally
Absorption
Well-absorbed in the gastrointestinal tract
Metabolism
In the liver
Excretion
Primarily in the urine
Potential Side Effects
Nausea, vomiting, allergic reactions
Dosage Instructions
Follow the prescribed dosage and consult with a healthcare professional before use.
Check Digit Verification of cas no
The CAS Registry Mumber 148720-14-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,7,2 and 0 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 148720-14:
(8*1)+(7*4)+(6*8)+(5*7)+(4*2)+(3*0)+(2*1)+(1*4)=133
133 % 10 = 3
So 148720-14-3 is a valid CAS Registry Number.
148720-14-3Relevant articles and documents
Synthesis and structure-activity study of protease inhibitors. V. Chemical modification of 6-amidino-2-naphthyl 4-guanidinobenzoate
Nakayama,Taira,Ikeda,Ashizawa,Oda,Arakawa,Fujii
, p. 117 - 125 (2007/10/02)
By developing 6-amidino-2-naphthyl 4-guanidinobenzoate (I, FUT-175) as a basic structure, its various derivatives were synthesized and their inhibitory activities on trypsin, plasmin, kallikrein, thrombin, C1r and C1s as well as on complement-mediated hemolysis were examined. The protective effect of these compounds on complement-mediated Forssman shock was also examined in guinea pigs. 6-Amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate (41, FUT-187) was found to be a suitable compound for oral administration with anti-complement activity superior to that of compound I.
